TG THERAPEUTICS INC (TGTX:NASDAQ)
$49.53 1.48 (3.0801%)
Analysed TG THERAPEUTICS INC (TGTX:NASDAQ) News Sources
A Look At TG Therapeutics (TGTX) Valuation After Recent Positive BRIUMVI Trial Updates
09-06-2026
yahoo.com
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
09-06-2026
yahoo.com
Sector Update: Healthcare Stocks Rise Pre-Bell Tuesday
09-06-2026
yahoo.com
TGTX Stock Jumps 5% On Positive Early Data For At-Home BRIUMVI In Muscle Disease
09-06-2026
stocktwits.com
Dow Jones Futures Tumble As Trump Says Iran Will 'Have To Pay The Price'; CPI Inflation On Tap
10-06-2026
yahoo.com
TGTX Rises on Positive Phase I Data for Subcutaneous Briumvi in MG
10-06-2026
yahoo.com
Why TG Therapeutics (TGTX) Is Up 18.4% After Advancing At‑Home Subcutaneous BRIUMVI In MS Treatment
10-06-2026
yahoo.com
Why This IBD Stock Of The Day, A Roche Rival, Just Broke Out To A Five-Year High
10-06-2026
yahoo.com
TG Therapeutics (TGTX) Soars 7.5%: Is Further Upside Left in the Stock?
11-06-2026
yahoo.com
Dow Jones Futures Signal Market Bounce, But Then What? Oracle Dives, SpaceX IPO On Launch Pad
11-06-2026
yahoo.com
What is the current price of TG THERAPEUTICS INC (TGTX:NASDAQ)?
The current price of TG THERAPEUTICS INC (TGTX:NASDAQ) is $49.53.
TG THERAPEUTICS INC (TGTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TG THERAPEUTICS INC (TGTX:NASDAQ) since the previous trading day is $1.48.
TG THERAPEUTICS INC (TGTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TG THERAPEUTICS INC (TGTX:NASDAQ) since the previous trading day is 3.0801%.
What is the most recent average sentiment score for TG THERAPEUTICS INC (TGTX:NASDAQ)?
The most recent average sentiment score for TG THERAPEUTICS INC (TGTX:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for TG THERAPEUTICS INC (TGTX:NASDAQ)?
The most recent sentiment for TG THERAPEUTICS INC (TGTX:NASDAQ) is .
SEC-8K** Filing Available For TG THERAPEUTICS INC (TGTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.